KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Invested Capital (2016 - 2025)

Historic Invested Capital for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $35.8 billion.

  • Boston Scientific's Invested Capital rose 1035.62% to $35.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $35.8 billion, marking a year-over-year increase of 1035.62%. This contributed to the annual value of $35.8 billion for FY2025, which is 1035.62% up from last year.
  • Boston Scientific's Invested Capital amounted to $35.8 billion in Q4 2025, which was up 1035.62% from $35.2 billion recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Invested Capital registered a high of $35.8 billion during Q4 2025, and its lowest value of $20.8 billion during Q4 2022.
  • In the last 5 years, Boston Scientific's Invested Capital had a median value of $27.8 billion in 2023 and averaged $28.9 billion.
  • As far as peak fluctuations go, Boston Scientific's Invested Capital tumbled by 1883.83% in 2022, and later skyrocketed by 3733.69% in 2023.
  • Over the past 5 years, Boston Scientific's Invested Capital (Quarter) stood at $25.7 billion in 2021, then decreased by 18.84% to $20.8 billion in 2022, then surged by 37.34% to $28.6 billion in 2023, then grew by 13.35% to $32.5 billion in 2024, then rose by 10.36% to $35.8 billion in 2025.
  • Its last three reported values are $35.8 billion in Q4 2025, $35.2 billion for Q3 2025, and $34.2 billion during Q2 2025.